Atlas Trials

Enzalutamide for Bladder Cancer Chemoprevention

Clinical trial NCT02605863 · TERMINATED

Trial details

NCT number
NCT02605863
Sponsor
University of Rochester
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2016-01-01
Primary completion
2018-02-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.